𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Further assessment of the clinically effective dose range of etoricoxib: a randomized, double-blinded, placebo-controlled trial in rheumatoid arthritis

✍ Scribed by Greenwald, M.; Peloso, P.M.; Mandel, D.; Soto, O.; Frontera, N.; Boice, J.A.; Zhan, X.J.; Curtis, S.P.


Book ID
125815977
Publisher
Informa plc
Year
2011
Tongue
English
Weight
523 KB
Volume
27
Category
Article
ISSN
0300-7995

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Efficacy of methotrexate treatment in pa
✍ Henrike van Dongen; Jill van Aken; Leroy R. Lard; Karen Visser; H. Karel Ronday; πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 124 KB πŸ‘ 2 views

## Abstract ## Objective To determine whether patients with undifferentiated arthritis (UA; inflammatory, nontraumatic arthritis that cannot be diagnosed using current classification criteria) benefit from treatment with methotrexate (MTX). ## Methods The PRObable rheumatoid arthritis: Methotrex